GSK buys US skincare company Stiefel
GSK buys US skincare company Stiefel
Monday 20th April 2009
The UK's biggest pharmaceutical company Glaxo Smith Kline (GSK) has announced a $3.6 billion (£2.5 million) deal to buy US skincare company Stiefel.Andrew Witty, GSK's chief executive officer, said: "This transaction will create a new world-leading, specialist dermatology business and re-energise our existing dermatology products.
"The addition of Stiefel’s broad portfolio will provide immediate new revenue flows to GSK with significant opportunities to enhance growth through leveraging our existing global commercial infrastructure and manufacturing capability.
"We look forward to working with Stiefel to develop this exciting opportunity."
Steifel specialises in treatments for acne and psoriasis. Its sales were $900 million last year, which combined with GSK's $550 million will give the new business an eight per cent share of the prescription skincare market.
When the deal is completed later this year, the new company will be led by Charles Stiefel, current head of the US company.
The deal comes just days after GSK announced an agreement with New York based pharmaceutical company Pfizer to merge the two companies' HIV drug businesses. The new company will have a 20 per cent share of the market providing vital drugs to HIV sufferers.
Related News
FTSE 100 back up over 4,000 - 16/04/09
The FTSE broke through the 4,000 level today with a rally that lasted much of the day
The FTSE broke through the 4,000 level today with a rally that lasted much of the day
Budget 2009: New £5,000 grant towards electric cars - 16/04/09
The government is proposing grants of up to £5,000 for motorists towards a new green car in a bid to harness the "untapped" potential of electric cars
The government is proposing grants of up to £5,000 for motorists towards a new green car in a bid to harness the "untapped" potential of electric cars
News Article Search
Quick Apply
News Archive